TremelImumab and Durvalumab Combination for the Non-OperatIve Management (NOM) of Microsatellite InstabiliTY (MSI)-High Resectable Gastric or Gastroesophageal Junction Cancer: The Multicentre, Single-Arm, Multi-Cohort, Phase II INFINITY Study

SIMPLE SUMMARY: The status of microsatellite instability (MSI-H) in gastric or gastroesophageal junction cancer (GC/GEJC) patients eligible for radical surgery proved to be prognostic for an improved survival outcome and predictive for poor/no benefit from the combination of adjuvant/peri-operative...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Cancers (Basel)
Prif Awduron: Raimondi, Alessandra, Palermo, Federica, Prisciandaro, Michele, Aglietta, Massimo, Antonuzzo, Lorenzo, Aprile, Giuseppe, Berardi, Rossana, Cardellino, Giovanni G., De Manzoni, Giovanni, De Vita, Ferdinando, Di Maio, Massimo, Fornaro, Lorenzo, Frassineti, Giovanni L., Granetto, Cristina, Iachetta, Francesco, Lonardi, Sara, Murialdo, Roberto, Ongaro, Elena, Pucci, Francesca, Ratti, Margherita, Silvestris, Nicola, Smiroldo, Valeria, Spallanzani, Andrea, Strippoli, Antonia, Tamberi, Stefano, Tamburini, Emiliano, Zaniboni, Alberto, Di Bartolomeo, Maria, Cremolini, Chiara, Sposito, Carlo, Mazzaferro, Vincenzo, Pietrantonio, Filippo
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: MDPI 2021
Pynciau:
Study Protocol
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC8201030/
https://ncbi.nlm.nih.gov/pubmed/34200267
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers13112839
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg